Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women

Exclusion Criteria

• •A history of allergic reactions to androgens (oral or patch), topical alcohol, or any component of the formulation
• •Any systemic skin diseases or local skin abnormalities in the area of application
• •Diagnosed with another primary female sexual dysfunction (e.g., Sexual Aversion Disorder, Female Sexual Arousal Disorder).
• •A medical condition that could affect or interfere with sexual function
• •Using a systemic topical gel or cream estrogen therapy.